SCHEMBL7301705

SCHEMBL7301705

CCOc1ccccc1N1CCN(C(=O)CCCn2c(=O)[nH]c(=O)c3ccccc32)CC1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.61
MEN1 O00255 1/20 0.57
USP2 O75604 1/20 0.57
GAA P10253 1/20 0.57
KMT2A Q03164 1/20 0.57
MAPT P10636 6/20 0.56
NPSR1 Q6W5P4 2/20 0.56
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
HTT P42858 1/20 0.56
HTR1A P08908 3/20 0.54
HTR7 P34969 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
HSD17B10 Q99714 1/20 0.52
NLRP1 Q9C000 1/20 0.50
ADRA1B P35368 1/20 0.49
DRD2 P14416 1/20 0.47
HTR2A P28223 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7301822 0.86 HTR1A (0.63) HTR1AHTR7ADRA1BDRD2HTR2A
SCHEMBL7308372 0.86 AR (0.57) LMNAMEN1USP2KMT2AMAPT
SCHEMBL7302783 0.81 MAPT (0.70) LMNAMEN1USP2GAAKMT2A
SCHEMBL7303413 0.81 MAPT (0.49) LMNAUSP2MAPTNPSR1ALDH1A1
SCHEMBL7305169 0.79 HTR1A (0.61) HTR1AHTR7ADRA1BDRD2HTR2A
SCHEMBL7300518 0.76 HTR7 (0.77) MEN1KMT2AHTR1AHTR7DRD2
SCHEMBL7308089 0.74 TNF (0.62) LMNAGAAMAPTKDM4EHSD17B10
SCHEMBL7300140 0.71 FABP4 (0.68) KDM4EALDH1A1HTR1AHSD17B10DRD2
SCHEMBL7306335 0.70 HSD17B10 (0.56) LMNAMEN1USP2KMT2AMAPT
SCHEMBL7297796 0.70 HTR1A (0.68) HTR1AHTR7ADRA1BDRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed